Kong X, Yao T, Zhou P, et al. Brown Adipose Tissue Controls Skeletal Muscle Function via the Secretion of Myostatin. Cell Metab. 2018;28(4):631-643.e3. doi:10.1016/j.cmet.2018.07.004
Muñoz JF, McEwen JG, Clay OK, Cuomo CA. Genome analysis reveals evolutionary mechanisms of adaptation in systemic dimorphic fungi. Sci Rep. 2018;8(1):4473. doi:10.1038/s41598-018-22816-6
Turcot V, Lu Y, Highland HM, et al. Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity. Nat Genet. 2018;50(1):26-41. doi:10.1038/s41588-017-0011-x
Wellington S, Hung DT. The Expanding Diversity of Mycobacterium tuberculosis Drug Targets. ACS Infect Dis. 2018;4(5):696-714. doi:10.1021/acsinfecdis.7b00255
Chang YL, Rossetti M, Vlamakis H, et al. A screen of Crohn’s disease-associated microbial metabolites identifies ascorbate as a novel metabolic inhibitor of activated human T cells. Mucosal Immunol. 2019;12(2):457-467. doi:10.1038/s41385-018-0022-7
Lopatkin AJ, Bening SC, Manson AL, et al. Clinically relevant mutations in core metabolic genes confer antibiotic resistance. Science. 2021;371(6531). doi:10.1126/science.aba0862
Bochner BR, Siri M, Huang RH, et al. Assay of the multiple energy-producing pathways of mammalian cells. PLoS One. 2011;6(3):e18147. doi:10.1371/journal.pone.0018147
Liu J, Lee J, Hernandez MAS, Mazitschek R, Ozcan U. Treatment of obesity with celastrol. Cell. 2015;161(5):999-1011. doi:10.1016/j.cell.2015.05.011
Rooks MG, Veiga P, Wardwell-Scott LH, et al. Gut microbiome composition and function in experimental colitis during active disease and treatment-induced remission. ISME J. 2014;8(7):1403-17. doi:10.1038/ismej.2014.3
Slavov N, Budnik BA, Schwab D, Airoldi EM, van Oudenaarden A. Constant growth rate can be supported by decreasing energy flux and increasing aerobic glycolysis. Cell Rep. 2014;7(3):705-14. doi:10.1016/j.celrep.2014.03.057